ARCHIVES

Rituximab and Fludarabine Combination Produces Long-Term Remissions in CLL

This article is from The Cancer Letter archive.

Vol. 34 No. 3 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

ODAC Rejects Temodal for Melanoma After Discussion Of Approval Standards

April 2, 1999

Response Oncology Sells Practice Back To Physicians.

March 2, 2001

Study Would Try to Validate EGFR FISH as Predictive Marker for Benefit from Tarceva.

July 13, 2007

NCI Getting a Lot For a Little Money It Spends Overseas, International Program Director Says

June 17, 1977

Waksals Keep ImClone Jobs, BMS Pumps $200M Into C225

March 8, 2002

NCCN Also to Warn Doctors. Amgen’s Pledges to Disclose Future Results.

February 23, 2007